Picard Medical prices $5M offering, exchanges high-price warrants for new $0.35 warrants

Picard Medical, Inc.

Gross proceeds ~$5M from selling 16.67M shares and common warrants at $0.30/unit.
Existing warrants for 7.01M shares at $2.675 exchanged for new warrants for 10M shares at $0.35.
New warrants eliminate forced exercise and anti-dilution provisions present in old warrants.
Net proceeds for working capital and payoff of senior secured note and working capital loans.
Offering expected to close May 6, 2026.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Picard Medical, Inc. entered into Warrant Issuance and Exchange Agreement with holder (the “Holder”) (effective 2026-05-05).

Action: entry
Counterparty: holder (the “Holder”)
Effective: 2026-05-05

Exact text from the filing

On May 5, 2026, Picard Medical, Inc. (the “Company”) entered into a Warrant Issuance and Exchange Agreement (the “Exchange Agreement”) with the holder (the “Holder”) of certain of the Company’s outstanding warrants to purchase shares of the Company’s common stock

View on SEC.gov

Browse all material agreements →

Picard Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-004529

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.